Contribution: Industrial Research Assistance Program – Contributions to Firms
Aurora Biosolutions Inc
$165,000.00
Anti-fibrotic engineered mesenchymal cells and development of potency assays for mesenchymal cell therapy products
FY 2018-19 · 2018-10-01
Summary
Mesenchymal stromal/stem cells (MSCs) exhibit numerous beneficial properties useful for a range of indications, including inflammatory diseases and regenerative medicine. We are developing an allogeneic engineered MSC product that promotes scar-less wound healing. We are also developing a biomarker screening assay for QC/QA to screen MSC potency and variability.
Department
Program
Industrial Research Assistance Program – Contributions to FirmsIndustrial Research Assistance Program-Contributions to Firms (linked with high confidence)
Recipient
Location
Port Moody|Port Moody, British Columbia, Canada
Recipient Type
For-profit organization
Business Number
822810180
Type
Contribution
Source
Proactive Disclosure - Grants and Contributions
Amendments
Each version of the agreement as published, oldest first, with its total as of that version. The amount above is the latest.
| Amendment | Date | Fiscal Year | Total |
|---|---|---|---|
| 0 | 2018-10-01 | 2018-19 | $74,000.00 |
| 1 | 2018-10-01 | 2018-19 | $84,000.00 |
| 2 | 2018-10-01 | 2018-19 | $154,000.00 |
| 3 | 2018-10-01 | 2018-19 | $164,000.00 |
| 4 | 2018-10-01 | 2018-19 | $165,000.00 |
As published
Additional Information
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 150 days. The total amended value is 1,000 dollars.
Additional Information (French)
Cet accord a été modifié 1 fois La date de fin du présent accord a été changé de 150 jours. La valeur totale des modifications est de 1 000 dollars.
Agreement End Date
2021-06-30
Agreement Number
914919
Agreement Start Date
2018-10-01
Agreement Title
Anti-fibrotic engineered mesenchymal cells and development of potency assays for mesenchymal cell therapy products
Agreement Title (French)
Cellules mésenchymateuses conçues par anti-fibrotiques et développement d'essais de puissance pour des produits de thérapie cellulaire mésenchymateuse
Agreement Type
Contribution
Agreement Value
$165,000.00
Amendment Date
2021-02-17
Amendment Number
4
Coverage
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation. | Les projets des Contributions aux entreprises stimulent la création de richesse au Canada grâce à l’innovation technologique.
Description
Mesenchymal stromal/stem cells (MSCs) exhibit numerous beneficial properties useful for a range of indications, including inflammatory diseases and regenerative medicine. We are developing an allogeneic engineered MSC product that promotes scar-less wound healing. We are also developing a biomarker screening assay for QC/QA to screen MSC potency and variability.
Description (French)
Les cellules souches / stromales mésenchymateuses (CSM) présentent de nombreuses propriétés bénéfiques utiles dans diverses indications, notamment les maladies inflammatoires et la médecine régénérative. Nous développons un produit CSM de conception allogénique, qui favorise la cicatrisation des plaies sans cicatrice. Nous développons également un test de dépistage de biomarqueurs pour le contrôle qualité / assurance qualité afin de détecter la puissance et la variabilité du CSM.
Expected Results
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Expected Results (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Federal Riding
Port Moody--Coquitlam
Federal Riding (French)
Port Moody--Coquitlam
Federal Riding Number
59023
NAICS Code
32541
Organization Code
nrc-cnrc
Organization
National Research Council Canada | Conseil national de recherches Canada
Program Name
Industrial Research Assistance Program – Contributions to Firms
Program Name (French)
Programme d’aide à la recherche industrielle – Contributions aux entreprises
Program Purpose
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Program Purpose (French)
Le PARI, par le biais des Contributions aux entreprises, vise à appuyer la recherche, le développement, l’adaptation et/ou l’adoption au Canada de produits, de services ou de processus novateurs ou axés sur des technologies nouvelles ou améliorées, et ce jusqu’à leur commercialisation
Recipient Business Number
822810180
Recipient City
Port Moody|Port Moody
Recipient Country
CA
Recipient Legal Name
Aurora Biosolutions Inc
Recipient Postal Code
V3H 4Z6
Recipient Province or Territory
BC
Recipient Type
F
Reference Number
172-2018-2019-Q3-914919
